Answers are grounded in this paper and cite their sources.
BACKGROUND AND OBJECTIVES: There is an increased interest in adaptive platform trials (APTs), that is, complex randomized clinical trials (RCTs) focusing on a population or a setting, conducted according to a core protocol, with continuous addition of interventions during trial conduct. APTs may run perpetually, assessing many different interventions. APTs come with benefits regarding increased flexibility, efficiency, and cost-effectiveness compared to conventional, stand-alone RCTs. However, planning APTs is complex, and limited guidance is available. METHODS: In this two-part series, we provide a narrative overview of key considerations for the planning of APTs in a clinical setting based on our own experiences planning and initiating APTs. RESULTS: The first part covered the following 5 overall considerations: stakeholder involvement, population and setting, interventions and comparisons, clinical outcomes, and adaptations. This second part covers 7 overall considerations: statistics and performance, other design features, data infrastructure, operations and organization, funding, dissemination, and implementation. CONCLUSION: The provided guidance on key considerations when planning APTs will aid researchers considering or planning APTs.
No takes yet. Share an insight, caveat, or question.
Møller et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: